INTERNATIONAL PATENT: TAIWANJ PHARMACEUTICALS CO., LTD., URCIA, BENJAMIN E. FILES APPLICATION FOR "DUAL FUNCTION COMPOUNDS FOR NADPH OXIDASE INHIBITION AND HISTONE DEACETYLASE INHIBITION"

GENEVA, April 8 -- TAIWANJ PHARMACEUTICALS CO., LTD. (3F.-4, No. 6-1, Sec. 2, Shengyi Rd., Zhubei CityHsinchu County, 302), URCIA, Benjamin E. (201 N. Union St., Ste. 320Alexandria, Virginia 22314) filed a patent application (PCT/US2025/041004) for "DUAL FUNCTION COMPOUNDS FOR NADPH OXIDASE INHIBITION AND HISTONE DEACETYLASE INHIBITION" on Aug 07, 2025. With publication no. WO/2026/072155, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEE, On (6F.-1, No. 63, Baoshan Rd., East Dist.Hsinchu City, 300), LIEN, Sheng-Chieh (...